Osteopenia in HIV Infection
The association between osteoporosis and HIV infection, identified serendipitously as many patients received body composition scans to assess lipodystrophy, has become the focus of increasing attention. Emerging data suggest that this phenomenon may represent yet another interaction between patient phenotype and antiretroviral therapy, such as occurs in the HIV lipodystrophy syndrome. This article will review the prevalence, possible pathogenesis, and potential management strategies for HIV-related osteopenia.
Welcome to Journal Watch. The content you requested requires sign in with a username and password.
Sign In
Sign Up
Print subscribers
Activate your free online account for full access to all site content and features.
Other visitors
Subscribe for full access to all site content and features. ($99/year)
Purchase a site pass for full access to all articles. ($19/7 days)
Or, simply register for free access to email alerts, site features, and article archives. (FREE)